Clinical results for Episealer® accepted for presentation at the 38[th] AGA Congress
Episurf Medical (Nasdaq: EPIS B) today announces that an abstract with results from follow-up of Episealer® Knee implant patients will be presented by Priv.-Doz. Dr. med. Clemens Kösters at the 38[th] annual AGA Congress in Innsbruck, Austria, which will take place on September 9-11. The abstract with the title “Good clinical results after implantation of single vs. multiple patient-specific mini-implants in therapy-resistant focal femoral (osteo-) chondral lesions in middle-aged patients” presents the clinical outcome for patients who received multiple Episealer® implants compared with